4.3 Article

Variable responses of formyl peptide receptor haplotypes toward bacterial peptides

期刊

IMMUNOGENETICS
卷 60, 期 2, 页码 83-93

出版社

SPRINGER
DOI: 10.1007/s00251-008-0277-3

关键词

chemoattractant receptor; inflammation; chemotaxis; cell signaling; haplotype

资金

  1. NCRR NIH HHS [P20 RR-016464, P20 RR016464] Funding Source: Medline
  2. NIAID NIH HHS [R01 AI051726-04, R01 AI051726, R01 AI51726] Funding Source: Medline
  3. NIDCR NIH HHS [R21DE16114, R21 DE016114] Funding Source: Medline

向作者/读者索取更多资源

The chemoattractant neutrophil formyl peptide receptor (FPR) binds bacterial and mitochondrial N-formylated peptides, which allows the neutrophils to find the bacterial source and/or site of tissue damage. Certain inflammatory disorders may be due in part to an impaired innate immune system that does not respond to acute bacterial damage in a timely fashion. Because the human FPR is encoded by a large number of different haplotypes arising from ten single-nucleotide polymorphisms, we examined the possibility that some of these haplotypes are functionally distinct. We analyzed the response of three common FPR haplotypes to peptides from Escherichia coli, Mycobacterium avium ssp. paratuberculosis, and human mitochondria. All three haplotypes responded similarly to the E. coli and mitochondrial peptides, whereas one required a higher concentration of the M. avium peptide fMFEDAVAWF for receptor downregulation, receptor signaling, and chemotaxis. This raises the possibility of additional bacterial species differences in functional responses among FPR variants and establishes a precedent with potentially important implications for our innate immune response against bacterial infections. We also investigated whether certain FPR haplotypes are associated with rheumatoid arthritis (RA) by sequencing FPR1 from 148 Caucasian individuals. The results suggested that FPR haplotypes do not significantly contribute toward RA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据